These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8516337)

  • 21. Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.
    Marks PA; Rifkind RA
    Environ Health Perspect; 1989 Mar; 80():181-8. PubMed ID: 2647479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
    Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of murine erythroleukemia cells results in the rapid repression of vimentin gene expression.
    Ngai J; Capetanaki YG; Lazarides E
    J Cell Biol; 1984 Jul; 99(1 Pt 1):306-14. PubMed ID: 6376521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiloride in differentiation and commitment of Friend erythroleukemia cells.
    Lubin M
    J Cell Physiol; 1985 Sep; 124(3):539-44. PubMed ID: 3862669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryoprotective agents as inducers of erythroleukemic cell differentiation in vitro.
    Preisler HD; Christoff G; Taylor E
    Blood; 1976 Mar; 47(3):363-8. PubMed ID: 1062223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythroleukemia cells: variants inducible for hemoglobin synthesis without commitment to terminal cell division.
    Marks PA; Chen Z; Banks J; Rifkind RA
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2281-4. PubMed ID: 6572977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
    Aroor AR; Singh LP; Wahba AJ
    Exp Hematol; 1995 Oct; 23(11):1204-11. PubMed ID: 7556531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid changes associated with erythroid differentiation of Friend erythroleukemia cells.
    Fallani A; Arcangeli A; Ruggieri S
    Toxicol Pathol; 1987; 15(2):170-7. PubMed ID: 3475757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and preliminary in vivo studies of compounds which induce the differentiation of Friend leukemia cells.
    Preisler HD
    Hamatol Bluttransfus; 1976; 19():161-7. PubMed ID: 1010465
    [No Abstract]   [Full Text] [Related]  

  • 30. Lithium inhibits terminal differentiation of erythroleukemia cells. Evidence for a pre-commitment 'priming' event.
    Zaricznyj C; Macara IG
    Exp Cell Res; 1987 Feb; 168(2):402-10. PubMed ID: 3026820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of erythroleukemia cells in vitro: properties of chemical inducers.
    Preisler HD; Lyman G
    Cell Differ; 1975 Jun; 4(3):179-85. PubMed ID: 1056810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.
    Marks PA; Breslow R; Rifkind RA; Ngo L; Singh R
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6358-62. PubMed ID: 2762329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of differentiation in mouse neuroblastoma cells by hexamethylene bisacetamide.
    Palfrey C; Kimhi Y; Littauer UZ
    Biochem Biophys Res Commun; 1977 Jun; 76(3):937-42. PubMed ID: 901454
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.
    Dell'Aquila ML; Nguyen HT; Herald CL; Pettit GR; Blumberg PM
    Cancer Res; 1987 Nov; 47(22):6006-9. PubMed ID: 3478136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases.
    Watanabe T; Kondo K; Oishi M
    Cancer Res; 1991 Feb; 51(3):764-8. PubMed ID: 1988116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of induced L-ornithine decarboxylase stimulation and erythrodifferentiation in Friend erythroleukemia cells by 2',5'-isoadenylate trimer core.
    Gazitt Y
    Cancer Res; 1981 Jul; 41(7):2959-61. PubMed ID: 6941849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of globin mRNA in relation to the cell cycle during induced murine erythroleukemia differentiation.
    Gambari R; Terada M; Bank A; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3801-4. PubMed ID: 278991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds.
    Reuben RC; Khanna PL; Gazitt Y; Breslow R; Rifkind RA; Marks PA
    J Biol Chem; 1978 Jun; 253(12):4214-8. PubMed ID: 275252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzyl alcohol alters the hemoglobin phenotype of mouse erythroleukemia cells.
    Scher W; Scher BM; Hellinger N; Waxman S
    J Biol Regul Homeost Agents; 1989; 3(3):91-7. PubMed ID: 2483024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C).
    Gerharz CD; Gabbert HE; Engers R; Ramp U; Mayer H; Luley C
    Br J Cancer; 1989 Oct; 60(4):578-84. PubMed ID: 2803927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.